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Current data indicate that many macrophage 
subsets and most DCs in nonlymphoid tissues and 
in the secondary lymphoid organs of mice origi-
nate and are renewed from bone-marrow he-
matopoietic stem cell–derived progenitors with 
myeloid-restricted differentiation potential (Fogg 
et al., 2006; Liu et al., 2009). However, excep-
tions must exist to this major pathway of macro-
phage and DC generation, because Langerhans 
cells (LCs) and microglia remain of host origin 
after syngeneic bone marrow transplant (Merad 
et al., 2002; Ajami et al., 2007; Mildner et al., 
2007), and LCs remain of donor origin after a 
limb graft (Kanitakis et al., 2004). Epidermal 
LCs have been shown to be a cycling pop-
ulation (Giacometti and Montagna, 1967; 
Czernielewski et al., 1985; Czernielewski and 
Demarchez, 1987). LC precursors were proposed 
to reside in the dermis (Larregina et al., 2001) 
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Most tissues develop from stem cells and precursors that undergo differentiation as their 
proliferative potential decreases. Mature differentiated cells rarely proliferate and are 
replaced at the end of their life by new cells derived from precursors. Langerhans cells (LCs) 
of the epidermis, although of myeloid origin, were shown to renew in tissues independently 
from the bone marrow, suggesting the existence of a dermal or epidermal progenitor. We 
investigated the mechanisms involved in LC development and homeostasis. We observed 
that a single wave of LC precursors was recruited in the epidermis of mice around embry-
onic day 18 and acquired a dendritic morphology, major histocompatibility complex II, 
CD11c, and langerin expression immediately after birth. Langerin+ cells then undergo a 
massive burst of proliferation between postnatal day 2 (P2) and P7, expanding their num-
bers by 10–20-fold. After the first week of life, we observed low-level proliferation of 
langerin+ cells within the epidermis. However, in a mouse model of atopic dermatitis (AD), a 
keratinocyte signal triggered increased epidermal LC proliferation. Similar findings were 
observed in epidermis from human patients with AD. Therefore, proliferation of differenti-
ated resident cells represents an alternative pathway for development in the newborn, 
homeostasis, and expansion in adults of selected myeloid cell populations such as LCs. This 
mechanism may be relevant in locations where leukocyte trafficking is limited.
© 2009 Chorro et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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We have previously shown that LCs develop normally in 
Rag/ c/ mice, indicating that LC development is inde-
pendent of the T cell lineage (Asli et al., 2004).
CX3CR1-GFP+ cells were already detectable in skin from 
E14 embryos but were located in the dermis and not in the epi-
dermis (Fig. 1 A). CX3CR1-GFP+ cells were first observed in 
the epidermis, in between epithelial cells, at E18 (Fig. 1 A). 
Flow cytometry analysis indicated that E18 epidermal 
CX3CR1-GFP cells expressed the M-CSF receptor (CD115, 
CSF-1R), the CD11b integrin Mac-1 (Fig. 1 B), and CD45 
(Fig. 2 A), but did not express significant levels of the Ly6C 
antigen. E18 epidermal CX3CR1-GFP cells lacked expres-
sion of Kit (CD117), FLT3 (CD135), CD11c, MHCII, and 
langerin, which characterize macrophage DC precursors 
(MDPs), common DC precursors (CDPs), preclassical DCs, 
and LCs (Fig. 1, B and C; and Fig. 2 A; Merad et al., 2008; Liu 
et al., 2009).
Between days 0 and 2 after birth, these epidermal 
CX3CR1-GFP cells start to acquire a dendritic morphology 
and expression of langerin, MHCII, and CD11c, characteris-
tics of differentiated LCs (Fig. 1 A and Fig. 2, A–D). At day 
4 after birth, most CX3CR1-GFP cells coexpressed langerin 
and MHCII (Fig. 2, D and E), indicating that at this stage, 
new CX3CR1-GFP langerin precursors are not recruited in 
the epidermis. Expression of CX3CR1-GFP was then pro-
gressively lost by epidermal LCs (Fig. 2 E), and adult LCs do 
not express CX3CR1 (Fig. 1 B). We did not observe any 
CX3CR1-GFP cells in the epidermis of adult Rag/ c/ 
CX3CR1-GFP mice (Fig. 1 B and Fig. 2 E).
These data indicate that a single wave of myeloid CD45+ 
CD115+ CD11b+ CX3CR1-GFP+ precursors is recruited in 
the epidermis before birth, around day E18, and differentiate 
into LCs in situ. These precursors have a phenotype distinct 
from the CDPs or preclassical DCs (Liu et al., 2007; Waskow 
et al., 2008). Their developmental relationship with bone 
marrow–derived cells that arise after E15 (Wolber et al., 2002; 
Bertrand et al., 2005) or with earlier E14 dermal CX3CR1-GFP+ 
cells, which are likely to derive from the fetal liver or yolk sack, 
remains to be investigated.
CD45+ CX3CR1+ epidermal precursors were evenly dis-
tributed in the epidermis and did not cluster around hair fol-
licles (Fig. 1 A). This is unlike the distribution observed in 
langerin–diphtheria toxin receptor mice after depletion, when 
bone marrow–derived cells were observed to colonize the 
epidermis in clusters (Bennett et al., 2005; Kaplan et al., 2007; 
Poulin et al., 2007).
Langerin+ MHCII+ cells proliferate massively and migrate  
to establish the LC network between postnatal day 4 (P4) 
and P7
From E18 to P2, the number of CD45+ CX3CR1+ precur-
sors remains low in the epidermis, at 50–100 cells/mm2  
(Fig. 3 A). However, between days 2 and 7, the number of 
newly differentiated LCs rapidly increased to reach 1,000/
mm2 (Fig. 3 A), whereas the size of individual LCs dramati-
cally decreased, as estimated using intravital microscopy in 
or in the hair follicle (Gilliam et al., 1998), and cells with 
features of proliferating LC precursors have been found in 
fetal and newborn skin (Elbe et al., 1989; Chang-Rodriguez 
et al., 2005). On the other hand, monocytes can give rise to 
LC-like cells in vitro (Geissmann et al., 1998; Mohamadzadeh 
et al., 2001), and LCs can be replaced by bone marrow–
derived cells in a selected experimental setting, i.e., after al-
logeneic bone marrow transplant, UV light irradiation, and 
conditional genetic ablation (Katz et al., 1979; Frelinger 
and Frelinger, 1980; Merad et al., 2002; Bennett et al., 
2005). The nature of the endogenous LC precursor is 
thus unclear.
LC development is controlled by M-CSF receptor and 
TGF-1 (Borkowski et al., 1996; Ginhoux et al., 2006; 
Kaplan et al., 2007), but the LC precursor is particularly enig-
matic because, in contrast to most organs, migration of 
leukocytes into the epidermis, as well as the brain, is rarely 
observed in a steady state; when such migration is observed, 
it is typically associated with inflammation. The mechanisms 
by which LCs develop and are renewed may differ from 
those involved in organs where hematopoietic cells circulate 
constantly, such as the spleen, liver, or lung. Although the 
roles of epidermal LCs remain controversial, recent evidence 
indicates a role as scavengers for viruses such as HIV-1 (de 
Witte et al., 2007) and possibly for carcinogens (Strid et al., 
2008), as well as their role in promoting and regulating T 
cell–mediated immune responses (Bennett et al., 2007; 
Stoitzner et al., 2008; Elentner et al., 2009; Vesely et al., 
2009). Understanding the mechanisms that control the 
development and homeostasis of DCs and macrophages in 
the skin or brain is thus of importance in understanding the 
pathophysiology of inflammation in these organs. In this 
study, we investigated the development of the LC network 
of the epidermis, and how it is maintained in a steady state 
and during epidermal inflammation.
RESULTS
CD115+ FLT3 CD45+ CX3CR1+ myeloid precursors colonize 
the epidermis between embryonic day 14 (E14) and E18 
and differentiate into langerin+ MHCII+ CX3CR1 LCs
Langerin+ MHCII+ cells become detectable in the epidermis 
after birth (Tripp et al., 2004); however, CD45+ CD3 cells, 
putative LC precursors, are first found in the skin of E17 
fetuses (Elbe et al., 1989). This LC precursor may be related 
to monocyte/macrophage and DC precursors, characterized 
by the expression of the chemokine receptor CX3CR1 (Auffray 
et al., 2009) and the hematopoietic-restricted phosphatase 
CD45. Therefore, we investigated whether it was possible to 
track LC precursors in the skin by examining whole-mount 
stainings of skin and epidermal sheets from CX3CR1-GFP 
reporter mice (Auffray et al., 2007). NK cells and epidermal 
 T cells can express CD11b and CX3CR1, and are a source 
of false positives in the analysis of myeloid cells using 
CX3CR1-GFP reporter mice; therefore, we used Rag/ 
c/ CX3CR1-GFP reporter mice devoid of lymphoid 
precursors and mature lymphocytes (Auffray et al., 2007). 
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Figure 1. Early recruitment of a CX3CR1+ CD45+ CD115+ CD11b+ myeloid precursor in the epidermis between E14 and E18. (A, top left) H&E stain-
ing and three-dimensional reconstruction of skin from E14 CX3CR1-GFP Rag/ c/ mice. CX3CR1+ cells are labeled in green and nuclei are labeled in blue. 
Confocal Z-stacks were acquired using a Leica SP5 microscope. Images show a 2–4-µm thick virtual section of the tissue. The dashed line indicates the separa-
tion between the dermis and epidermis. CX3CR1+ cells can be detected in the dermis but not in the epidermis. Results are representative of 10 skin samples per 
mouse (n = 4). (top right and bottom) Tiled micrographs of epidermal sheets of CX3CR1-GFP Rag/ c/ E18 fetuses and pups at P0 (the day of birth) and P2. 
CX3CR1+ cells are labeled in green. Tiles were obtained by assembling a series of maximal intensity projections of Z-stacks. (insets) Enlarged CX3CR1+ cells (green) 
and nuclei (white). CX3CR1-expressing cells are first detected in the epidermis at E18, and acquire a dendritic shape between P0 and P2 (n = 3–4 mice for each 
time point). (B, top) Flow cytometry analysis of epidermal cells from E18 CX3CR1-GFP Rag/ c/ embryos and 10-wk-old langerin-GFP mice. Cells were la-
beled with antibodies against CSF-1R (CD115), Flt3 (CD135), c-kit (CD117), I-A, CD11c, CD11b, and Lyc6 and analyzed by multicolor flow cytometry. Dot plots 
show the gate used for analysis of GFP-expressing LC precursors and adult LCs. Overlaid histograms show the expression of surface markers on gated GFP+ cells 
(red line) and control (fluorescence minus one; black line). Results are representative of three to five experiments with similar results. (bottom) Micrographs 
display maximal intensity projections of Z-stacks from epidermal sheets of 10-wk-old CX3CR1-GFP Rag/ c/ mice. CX3CR1-expressing cells are labeled in 
green and langerin is labeled in red. Results are representative of 12 0.03-mm2 Z-stacks per mouse (n = 4). Adult LCs do not express CX3CR1 (GFP). (C) Flow 
cytometry analysis of bone marrow MDPs and CDPs. Bone marrow cells from adult CX3CR1-GFP Rag2/ c/ mice were labeled with antibodies against lin-
eage markers (CD11b, NK1.1, CD3, Ter119, and CD19), c-kit (CD117), Flt3 (CD135), CSF-1R (CD115), CD11c, and I-A and analyzed by multicolor flow cytometry. 
MDPs are defined as CX3CR1high (GFP) c-kit+ lineage, whereas CDPs are defined as lineage c-kitlow Flt3+ . Overlaid histograms show expression of surface 
markers on gated MDPs and CDPs (red line) over control (black line). Results are representative of three to five experiments with similar results. SSC, side scatter.
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at E18, whereas this number decreased to <10% at P0 and P2 
(Fig. 3 B). No mitotic figures were observed in epidermal 
CX3CR1+ cells at P2 and P0, and in only 1 out of 800 cells was 
the presence of two nuclei in the same cytoplasm observed in 
the epidermis of an E18 embryo (Fig. S2). These data suggest 
that CX3CR1+ cells are derived from a proliferating precursor, 
whereas they do not actively proliferate inside the epidermis.
In contrast, analysis at day 4 after birth indicated that 
60–70% of epidermal langerin+ cells were recently cycling 
(Fig. 3 C). Three-dimensional reconstruction analysis of 
whole-mount epidermis identified numerous langerin+ cells 
at various stages of the mitotic process (Fig. 3 D, Fig. S3, and 
Video 1). To confirm in situ proliferation of LCs in the 
langerin-GFP reporter mice (Fig. S1; Elbe et al., 1989; 
Kissenpfennig et al., 2005). Similar kinetics of LC expansion 
were observed in CCR2/ mice (Fig. 3 A). The absence of 
epidermal CX3CR1+ langerin cells at day 4 (Fig. 2 B) and 
the results from CCR2/ mice indicated that LC expansion 
may rely on a mechanism distinct from the CCR2-depen-
dent recruitment of precursors from blood that has been ob-
served for the recruitment of LCs after UV treatment or 
genetic depletion (Ginhoux et al., 2006; Poulin et al., 2007).
Analysis of cell proliferation using Ki67 staining on epider-
mal sheets from Rag/ c/ CX3CR1-GFP and langerin-
GFP mice indicated that 20% of myeloid CD45+ CX3CR1+ 
LC precursors, scattered across the epidermis, expressed Ki67+ 
Figure 2. Epidermal CX3CR1+ CD45+ myeloid precursors differentiate into langerin+ MHCII+ LCs between E18 and P2. Expression of (A) CD45,  
(B) langerin, and (C) MHCII. Maximal intensity projections of Z-stacks from epidermal sheets of CX3CR1-GFP Rag/ c/ mice at E18, P0, P2, and P4 are dis-
played. CX3CR1-expressing cells are labeled in green and CD45, langerin, and MHCII are labeled in red using antibodies. Results are representative of 20 0.01-
mm2 Z-stacks per time point and per mouse (n = 3 mice per experimental time point). (D) Bar graph showing the percentage of epidermal CX3CR1-GFP+ cells 
expressing CD11c, langerin, or MCHII (I-A) at P0, P2, and P4. For each mouse, a range of 200–800 cells was analyzed. Means ± SD are displayed (n = 1–3 mice 
per experimental point). (E) Bar graph shows the percentage of epidermal cells expressing CX3CR1 but not langerin, both CX3CR1 and langerin, or langerin 
only at P0, P2, P4, and 8 wk. For each mouse, a range of 300–1,000 cells was analyzed. Means ± SD are displayed (n = 3–4 mice per experimental point).
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epidermis, we purified langerin+ LCs from epidermal sheets 
from P4 and P7 langerin-GFP mice, and analyzed their DNA 
content using propidium iodide (PI). In P4 mice, 26 ± 4% of 
langerin-GFP cells contained >2N DNA, and were therefore 
in the S/G2/M phase of the cell cycle (Fig. 3 E and Fig. S4). 
The percentage of LCs in S/G2/M at day 7 was lower (13 ± 
3%; Fig. 3 E). The results from PI staining are thus consistent 
with the kinetics of Ki67 staining and the mitotic figures ob-
served in situ. As discussed, the drop in the percentage of 
CX3CR1+ langerin cells observed in the epidermis between 
P2 and P4 (Fig. 2 B) indicates that the recruitment of new 
precursors is unlikely to contribute to the establishment of 
the LC network. In addition, we have used the least square 
methods to calculate the number of LCs per square millime-
ter that would be obtained between days 2 and 7 if each di-
viding LC (observed values using flow cytometry analysis of 
PI staining) was dividing once, twice, or three times per day 
in the absence of the recruitment of new precursors. This 
analysis indicated that dividing LCs must undergo between one 
and two divisions per day to fit our observed data (Fig. 3 F). 
Figure 3. LCs expand in the epidermis by proliferating during the 
first week of life to establish an LC network. (A, left) Kinetic of the 
number of CX3CR1+ cells per square millimeter of epidermis of CX3CR1-
GFP Rag/ c/ mice at various ages (E14, E18, P0, P1, and P2). 
CX3CR1+ cells appear slowly in the epidermis between E18 and P2. Cells 
were enumerated as indicated in Materials and methods. Each dot repre-
sents an individual mouse. (right) Kinetic of the number of langerin-GFP+ 
cells per square millimeter of the epidermis of langerin-GFP CCR2+/ or 
langerin-GFP CCR2/ mice at various ages (P2, P4, P5, and P7). The 
epidermis was studied by intravital microscopy in live animals, as indi-
cated in Materials and methods. LCs rapidly expand between P2 and P7. 
Each dot represents an individual mouse. Representative micrographs of 
maximal intensity projections of Z-stacks obtained at various time points 
are displayed below the graph. (B, top) Micrographs of epidermal sheets 
of CX3CR1-GFP Rag/ c/ mice at various ages (E18, P0, and P2). 
CX3CR1+ cells are labeled in green and Ki67 is labeled in red. Images are 
optical slices from Z-stacks (optical zoom factor 2). (bottom) The graph 
shows the percentage of CX3CR1+ cells expressing the nuclear prolifera-
tion marker Ki67 at various ages. For each mouse, a range of 100–500 
cells was analyzed. Each dot represents an individual mouse. (C) Same as 
in B. Langerin-GFP CCR2+/ or langerin-GFP CCR2/ mice at various 
ages (P2, P4, and P7) were analyzed. Horizontal lines represent means. 
(D) LC mitosis within the epidermis. Micrographs of langerin-GFP+ cells 
(green) expressing Ki67 (red) from epidermal sheets of P4 langerin-GFP 
mice. Pictures are optical slices from Z-stacks (optical zoom factor 2). 
Results are representative of six mice. For more information, see Fig. S3 
and Video 1. (E) Cell-cycle analysis by PI staining of sorted P4 and P7 LCs 
by flow cytometry. Dot plots show the gate used for GFP-expressing LC 
sorting. Percentages of GFP+ cells among all events are indicated. Histo-
grams show the cell-cycle analysis. Percentages of gated singlet PI+ 
events in the S/G2/M phase are indicated. Means of three and two inde-
pendent experiments ± SD at P4 and P7, respectively, are indicated.  
(F) Estimate of the duration of the langerin+ cell-cycle during the first 
week of life. Using a nonlinear regression model (sigmoidal curve) based 
on data from A (R-squared value of the trend line = 0.98) and cell-cycle 
data from E, we formulated a polynomial regression model to extrapo-
late the percentage of cells proliferating at each day after birth (0–7 d), 
and we calculated the total number of cells per square millimeter over 
time that would be obtained considering one (red line), two (yellow line), 
or three (green line) divisions per day per dividing cell. Experimental data 
are represented by blue diamonds. The graph shows that experimental 
data fit with a model of in situ proliferation of LCs in which the length 
of the cell cycle is between 12 and 24 h. SSC, side scatter.
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and 14-wk-old langerin-GFP mice indicated that 5–7% of LCs 
expressed Ki67 (Fig. 4, A and B; and Video 2). The number of 
LCs in the steady state was not affected in CCR2/ mice 
(Fig. 4 B). As exemplified by epidermal sheets from an 8-wk-old 
mouse (Fig. 4 A), Ki67+ cells were evenly distributed in the skin 
and did not seem to cluster around hair follicles. The distance 
between LCs and their closest neighbor was shorter in the case 
of pairs of Ki67+ LCs, which frequently formed doublets, sug-
gesting that LCs may divide within the epidermis and that 
daughter cells migrate away from each other (Fig. 4, A and C). 
Indeed, three-dimensional reconstructions demonstrated lan-
gerin+ mitotic figures within the epidermis (Fig. 4 D, Video 3, 
and Video 4). Moreover, 5% of LCs from the epidermis of 10-
wk-old mice were in the S/G2/M phase of the cell cycle based 
on PI staining (Fig. 4 E). Analysis of epidermal sheets from wild-
type mice 7 wk after a bone marrow transplantation with 
This fit well within the current understanding of the duration 
of the cell cycle in eukaryotic cells outside stem cells (Alberts 
et al., 2002), and thus, given their high proliferation index, a 
reasonable proliferation rate of langerin+ LCs is sufficient to 
explain their rapid increase in number.
Collectively, these data demonstrate that a single wave of 
CX3CR1+ CD45+ langerin LC precursors enters the skin 
between E18 and P2 and differentiates into CX3CR1low 
CD45+ langerin+ MHCII+ CD11c+ LCs, and then langerin+ 
LCs undergo a massive burst of proliferation during the first 
week of life, a result consistent with the observations by 
Chang-Rodriguez et al. (2005).
Proliferation of resident epidermal LC in the steady state
We next investigated whether LCs also proliferated in the 
adult epidermis. Analysis of large epidermal sheets from 4-, 8-, 
Figure 4. Proliferation of resident epidermal LCs in the steady state. (A) Tiled micrograph of ear epidermal sheets of a 8-wk-old langerin-GFP 
mouse. LCs are labeled in green and Ki67 is labeled in red. This tile has been obtained by assembling a series of maximal intensity projection Z-stacks. 
Ki67-expressing LCs are indicated with white circles. (inset) A three-dimensional reconstruction of a Ki67+ LC as in D (for more information see Video 2). 
Results are representative of epidermal sheets from four mice. (B, left) The percentage of Ki67+ langerin-GFP+ cells at various ages (W4, 4 wk; W8, 8 wk; 
W14, 14 wk). For each animal, 160–400 cells were analyzed. Means ± SD are displayed (n = 4 mice per experiment). (right) The number of langerin+ cells 
per square millimeter in the ear epidermis of littermate 4-wk-old CCR2+/+ and CCR2/ mice. Means of three experiments ± SD are displayed. (C) Graph 
shows the distance in micrometers between LCs and their closest neighbor. More than 600 langerin-GFP+ cells and >60 Ki67+ langerin-GFP+ cells were 
analyzed from the epidermis of 8-wk-old langerin-GFP+ mice. Similar results were obtained from the epidermis of 4- and 14-wk-old mice (n = 4).  
(D) Snapshots of a three-dimensional reconstruction of Z-stacks of 8-wk-old Ki67-expressing epidermal langerin-GFP+ cells using Imaris software. Re-
sults are representative of epidermal sheets from four mice. For more information, see Video 3 and Video 4. (E) Cell-cycle analysis by flow cytometry of 
sorted LCs as in Fig. 3 E. Percentages of gated singlet PI+ events in the S/G2/M phase are indicated. The experiments have been repeated three times with 
similar results. (F, top) CD45.1+ C57BL/6 recipient mice were irradiated (10 Gy) and injected with107 bone marrow cells obtained from adult langerin-GFP 
CD45.2+ mice to allow identification of donor-derived cells. 5 wk after transplantation, hematopoietic engraftment was analyzed by measurement of 
blood chimerism, and ears were collected 7 wk after transplantation. (bottom) Micrographs of epidermal sheets of control langerin-GFP mice and of ir-
radiated chimeric mice. Langerin-GFP+ cells are labeled in green (anti-eGFP antibody) and langerin+ cells are labeled in red (antilangerin antibody). Maxi-
mal intensity projections from Z-stacks are displayed. Results are representative of epidermal sheets from four mice. HF, hair follicle; SSC, side scatter.
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We obtained epidermal sheets from the skin of two patients 
with AD. Ki67+ langerin+ cells accounted for 13 and 16% of 
epidermal LCs (Fig. 6, C and D), suggesting that proliferation 
of LCs is also increased in humans with AD. Although the 
precise role of LCs in allergic diseases is still debated, a con-
cordant increase in LC proliferation in patients with human 
AD and in a mouse model for the disease suggests a potential 
relevance for the pathophysiology of the disease.
DISCUSSION
Our results indicate that although monocytes and classical DCs 
constantly renew from a proliferating bone marrow MDP 
(Fogg et al., 2006; Liu et al., 2009), LCs renew from the pro-
liferation of resident, differentiated LCs. CD115+ CD135 
CD11b+ CD45+ CX3CR1+ LC precursors enter the skin 
before birth as a single wave of recruitment around E18. 
These precursors, evenly distributed in the epidermis, differ-
entiate into LCs expressing langerin, MHCII, and CD11c 
between P0 and P4. Langerin+ LCs then undergo a burst of 
proliferation that increases their numbers by >10-fold and 
establishes the LC network. In contrast to our observations, 
results published by Bennett et al. (2005), Kaplan et al. (2007), 
and Poulin et al. (2007) show that after genetic depletion, LCs 
first appear in clusters, and the replenishment of genetically 
depleted mice is very slow and takes up to 7 wk. This may be 
because in this model rare and scattered precursors are respon-
sible for LC replenishment. In contrast, the absence of clusters 
and the fast development of the network during the first week 
of life in the physiological condition, as we describe in this 
study, can easily be explained by the high number and the 
even distribution of precursors present at birth.
According to our data, the LC network appears to be 
maintained throughout life by slow proliferation of epider-
mal langerin+ LCs rather than from a dermal or hair follicle 
precursor, as previously proposed (Merad et al., 2008). More-
over, a surprising result from this study is that the resident 
langerin+ LCs can indeed be induced to massively proliferate 
by a keratinocyte signal in adults, showing that epidermal 
LCs can expand in the epidermis independently of a bone 
marrow input in a steady state as well as during inflammation. 
These results differ markedly from observations after UV 
treatment and during GVHD, when bone marrow–derived 
langerin+ cells were observed, using flow cytometry, to 
replace LCs in the epidermis (Merad et al., 2002; Ginhoux et 
al., 2006). However, it is at this time difficult to compare AD 
with the UV and GVHD models. In UV treatment and 
GVHD, LCs are killed, which makes it difficult to study their 
proliferation, and the dermis is heavily infiltrated by bone 
marrow–derived inflammatory cells, which can express lan-
gerin and can infiltrate the upper dermis and epidermis.
Collectively, the present data suggest a new model for the 
renewal of resident cells in which a single wave of progenitors 
seeds tissue and differentiates before proliferating to establish 
a population of resident cells that will reenter the cell cycle to 
ensure homeostasis and expansion, when required, based on 
signals from the microenvironment (Fig. 7). It remains to be 
bone marrow cells from langerin-GFP mice confirmed 
previous findings (Merad et al., 2002) because all epider-
mal LCs were GFP (Fig. 4 F). Collectively, these data in-
dicate that LCs continuously proliferate in the epidermis 
of mice.
Keratinocyte signals can drive a massive proliferation of LCs 
during skin inflammation
These findings raised the question of the mechanism involved 
in LC renewal during inflammation in the absence of radical 
depletion of LCs and/or of disruption of the epidermal basal 
membrane, such as that obtained with UV irradiation, genetic 
depletion, or graft-versus-host disease (GVHD; Bennett et al., 
2005; Kaplan et al., 2005; Kissenpfennig et al., 2005; Merad 
et al., 2002). Treatment of mice with the vitamin D3 ana-
logue MC903 induces the production of thymic stromal lym-
phopoietin (TSLP) by keratinocytes, which in turn is both 
required and sufficient to induce a skin and systemic inflam-
mation that resembles human atopic dermatitis (AD; Li et al., 
2006; Li et al., 2009). Akin to what is observed in humans, 
the epidermis of mice became thicker, and we observed that 
LC numbers were increased after 2 wk of treatment (Fig. 5, 
A and B). Analysis of Ki67 expression indicated a strong local 
proliferation of LCs with 25–35% of langerin+ Ki67+ cells 
(Fig. 5 C). Bone marrow chimera experiments indicated that 
only rare bone marrow–derived langerin cells could be de-
tected in the epidermis of MC903-treated mice after 2 wk of 
treatment, and these cells were not proliferating (Fig. 5 D). 
We investigated whether MC903 acted directly on LCs by 
comparing LC proliferation in vitamin D receptor–deficient 
(VDR/) mice, in which all cells lack VDR (Fig. 5 E), and 
VDRf/fxK14-cre mice (VDRep/), in which keratinocytes 
but not LCs lack the receptor (Fig. 5 F). LC proliferation was 
completely dependent on VDR, indicating that LC prolifera-
tion is triggered in vivo by a keratinocyte signal that is trans-
activated by vitamin D and VDR. The keratinocyte signal is 
distinct from TSLP, because LC proliferation was comparable 
in TSLP/ mice and controls in the neonatal period, in adults 
in a steady state, and during MC903 treatment (Fig. S5). 
Of note, steady-state LC proliferation did not require VDR 
(Fig. 5 E). These findings also suggest that different mechanisms 
might be involved in LC production in adult animals de-
pending on whether LCs are previously depleted and/or the 
epidermal basal membrane is disrupted (as with UV irradiation, 
genetic depletion, and GVHD; Merad et al., 2002; Bennett 
et al., 2005; Kaplan et al., 2005; Kissenpfennig et al., 2005), 
or if LC expansion is induced in an LC-replete animal with 
an “intact” skin.
Human epidermal LCs proliferate in the steady state,  
and proliferation is increased in two patients with AD
Ki67+ langerin+ cells were also present in epidermal sheets 
from healthy human donors, where they accounted for 2–4% 
of epidermal LCs, suggesting that human epidermal LCs also 
proliferate within the epidermis, as proposed earlier (Fig. 6, 
A–C; and Video 5; Czernielewski and Demarchez, 1987). 
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studied whether all LCs will keep the ability to proliferate 
during adult life or if proliferation is caused by a subset of 
langerin+ LCs. In situ fate mapping experiments of individual 
cells will be required to answer this question. However, the 
high index of proliferation observed during inflammation 
(30% of LCs staining with anti-Ki67 antibodies) suggests that 
Figure 5. A keratinocyte-derived signal can drive a massive proliferation of LCs during skin inflammation. (A) Time course of treatment of the 
ears of mice with MC903 or ethanol. Analysis of the epidermis was performed at days 4 and 14. (B) Graphs show the number of langerin+ cells per square 
millimeter in the epidermis of wild-type mice treated with MC903 (white) or ethanol (black). Means ± SD are displayed (n = 3). (C) Micrographs are repre-
sentative maximal intensity projections (left) or optical slices (right) of Z-stacks from epidermal sheets of mice treated for 14 d. Langerin+ cells are either 
labeled in red (left) or in green (right), and Ki67 is labeled in red (right). Results are representative of epidermal sheets from two to three animals. The graph 
shows the percentage of langerin+ cells expressing Ki67 after 14 d of MC903 (white) or ethanol (black) treatment. For each animal, 150–300 langerin+ cells 
were analyzed. Means of two to three experiments ± SD are displayed. (D) Similar to the experiment described in Fig. 4 F. 7 wk after transplantation, MC903 
or ethanol was applied on the ear every other day for 14 d. Micrographs show epidermal sheets from MC903-treated ears (top) or epidermal sheets from 
control ethanol-treated ears (bottom). (left) Langerin-GFP+ cells are labeled in green (anti-eGFP antibody) and langerin+ cells are labeled in red (antilangerin 
antibody). Maximal intensity projections from Z-stacks are shown. Results are representative of 10 0.56-mm2 Z-stacks per mice. The pictures show few 
(<1%) bone marrow–derived LCs recruited in the epidermis of MC903-treated mice after 2 wk of treatment. (right) Langerin-GFP+ cells (green) are not 
labeled with Ki67 (red). The pictures show two representative examples of langerin-GFP+ cells recruited in the epidermis after MC903 treatment. For each 
animal, >500 Ki67+ cells were analyzed. (E) Treatment of VDR/ mice with MC903 or ethanol. Mice were treated with MC903 or ethanol as in A, and analy-
sis of the epidermis was performed at day 14. The bar graph represents the percentage of langerin+ cells expressing Ki67 in VDR+/+ or VDR/ mice either 
untreated (gray bar) or treated for 14 d with MC903 (white bar) or ethanol (black bar). For each animal, 250–600 langerin+ cells were analyzed. Means of 
two experiments ± SD are displayed. (F) Similar to the experiment described in E but performed on VDRep+/+ and VDRep/ mice. HF, hair follicle.
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mechanism is responsible for the development and homeostasis 
of microglia.
The precise role of LCs in the immune response, par-
ticularly in allergic diseases such as AD, is still debated. 
A recent study proposed that LCs are important for the 
development of this disease (Elentner et al., 2009). The 
concordant increase in LC proliferation in human AD and 
a mouse model for the disease observed in our study may 
suggest that LC proliferation is of physiological relevance 
in this allergic disease. Finally, among outstanding ques-
tions, the origin of the epidermal LC precursor and the 
mechanisms by which it enters the epidermis around E18 
are not known.
It is possible that the precursors recruited in the epidermis 
around E18 originate from bone marrow–derived cells, such as 
MDPs, after the location of fetal hematopoiesis begins to switch 
from the fetal liver to fetal bone marrow at E15 (Wolber et al., 
2002; Bertrand et al., 2005). It is also possible that the epider-
mal precursor originates from the CX3CR1+ cells that we have 
detected in the dermis of fetuses at E14 (Fig. 1 A) and that may 
derive from the fetal liver or yolk sack. Adoptive transfer of 
the fraction of LCs that keeps the potential to enter the cell 
cycle must be relatively high.
The present results thus indicate that the microenviron-
ment of LCs, e.g., keratinocyte signals, is likely to play a 
major role in the control of LC homeostasis, in line with the 
ability of keratinocytes to produce M-CSF and TGF-1, 
which have been shown to be required for the development 
of the LC network (Chodakewitz et al., 1990; Borkowski 
et al., 1996; Ginhoux et al., 2006; Kaplan et al., 2007). Other 
cytokines are involved in LC biology, such as TLSP and 
RANKL (Barbaroux et al., 2008), but our data do not sup-
port a major role for TSLP in the control of LC proliferation 
during development and inflammation.
The alternative pathway for the development and re-
newal of mononuclear phagocytes that we describe in this 
paper may be useful in organs, such as the epidermis, that 
lack blood vessels and are not sites of active leukocyte extrav-
asation, or that must be protected against the entry of in-
flammatory cells. Notably, as brain microglia also renew 
independently of the bone marrow (Ajami et al., 2007; Mildner 
et al., 2007), it will be interesting to investigate if a similar 
Figure 6. Proliferation of human LCs in the epidermis from healthy controls and AD patients. Epidermal sheets were obtained from four 
healthy donors and two AD patients and analyzed by confocal microscopy for expression of langerin (green) and Ki67 (red). (A) Representative maxi-
mal intensity projections of Z-stacks of healthy epidermis. Ki67+/langerin+ LCs are circled in white, and nuclear localization of Ki67 was confirmed by 
three-dimensional visualization (for more information see Video 5). (B) Ki67+ LC doublets were detected in human epidermis. (C) A significantly higher 
percentage of Ki67+ LCs was observed in AD epidermis compared with healthy controls (14.5 ± 1.55% and 3.21 ± 0.33%, respectively; P = 0.003 ; n = 2 
and 4, respectively). A minimum of 500 LCs, as visualized by langerin expression, were analyzed per healthy donor and patient. Results are expressed 
as mean percentages of Ki67+LCs ± SD. (D) Representative maximal intensity projections of Z-stacks of epidermis from AD patients. A group of three 
Ki67+ LCs is shown as a three-dimensional reconstruction. Ki67+/langerin+ LCs are circled in white. The scale is graduated in micrometers.
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For hematoxylin and eosin (H&E) staining, whole embryos were fixed 
for 1 wk in neutral buffer formalin (Genta Medical) before paraffin embed-
ding. 6-µm sections were labeled with H&E. After mounting, embryo sec-
tions were imaged using a microscope (Axiophot; Carl Zeiss, Inc.).
Preparation and immunostaining of human epidermal sheet. 6-mm 
punch skin biopsies from four healthy donors and two AD patients (non–steroid 
treated) were obtained after informed consent and approved by the St. Thomas’ 
Hospital Research Ethics Committee (reference number 06/Q0702/138), and 
were incubated for 2 h at 37°C in PBS containing 20 mM EDTA. The epider-
mis was separated from the underlying dermis using forceps and washed several 
times in PBS. Epidermal sheets were fixed in PBS with 4% formaldehyde at 
4°C for 45 min and subsequently washed in PBS. Sheets were stained over-
night at room temperature in 500 µl PBS 0.25% Triton X-100 with anti-Ki67 
antibody (diluted 1:500; Abcam) and anti–human langerin-PE antibody (di-
luted 1/10; Coulter Immunotech). Samples were washed twice in PBS 0.1% 
Tween and incubated for an additional 2 h at room temperature in 300 µl PBS 
0.25% Triton X-100 with goat anti–rabbit Alexa Fluor 488 antibody (diluted 
1:300; Invitrogen) and donkey anti–mouse IgG1 Cy3 (diluted 1:300; Jackson 
ImmunoResearch Laboratories, Inc.) before mounting.
Image acquisition and quantitative analysis. All Z-stack acquisitions 
were done using a confocal microscope (SP5; Leica) with 20× and 40× 
lenses. The number of LCs per square millimeter of epidermis was deter-
mined by acquiring Z-stacks of immunolabeled epidermal sheets. A mini-
mum of four Z-stacks (0.56 mm2/Z-stack) were acquired per epidermal 
sheet. The number of cells per Z-stack was enumerated and represented as 
cells per square millimeter. The distance between a langerin-GFP+ cell and 
its closest GFP+ neighbor (Ki67+ or Ki67) was measured on a maximal in-
tensity projection of Z-stacks of immunolabeled epidermal sheets. All image 
quantification and rendering was performed on MetaMorph (MDS Analyti-
cal Technologies) and Imaris (Bitplane) software.
Intravital microscopy. Langerin-GFP CCR2+/ or CCR2/ mice of 
various ages (P2–P7) were anesthetized using 25 mg/kg ketamine, 5 mg/kg 
xylazine, and 0.8 mg/kg acepromazine injected intraperitoneally. Mice were 
kept at 37°C with oxygen (0.5 liter/min). Mice abdomens were placed on a 
custom-made tray-stage insert with a circular 2.5-cm hole covered with a 
coverslip. Images were acquired using an inverted confocal microscope 
(LSM 510; Carl Zeiss, Inc.) equipped with a 20×/0.75 Plan Apochromat 
objective. A thermostated chamber (Carl Zeiss, Inc.) was used to keep the 
microscope, mouse, tray, and objective at 37°C during the experiment. 
putative precursors into fetuses and embryos will help answer 
this question, but it may be a difficult experiment.
MATERIALS AND METHODS
Animals. CX3CR1-GFP Rag/ c/ (Auffray et al., 2007), langerin-
GFP (Kissenpfennig et al., 2005), VDR/, VDRep/, and TSLP/ mice 
(Li et al., 2006; Li et al., 2009) have been previously described. CCR2/ 
mice were provided by I. Charo (Gladstone Institute of Cardiovascular Dis-
ease, University of California, San Francisco, San Francisco, CA). Mice were 
maintained in specific pathogen-free animal facilities at the University Paris-
Descartes, King’s College London, Institut de Génétique et de Biologie 
Moléculaire et Cellulaire, and Institut Biologie Moléculaire et Cellulaire 
(Strasbourg, France). All animal protocols were approved by the Institutional 
Committees on Animal Welfare of the University Paris-Descartes and of the 
United Kingdom Home Office.
Preparation and immunolabeling of mice epidermal sheets. Mice of 
defined ages, ranging from E14 to P7, were sacrificed. Ventral skin was dis-
sected, cut into 1 × 1–cm pieces, and placed dermal side down on PBS 
20 mM EDTA for 2 h at 37°C. The epidermis was then peeled off the der-
mis. For E14 fetuses, whole skin was processed. To prepare epidermal sheets 
from adult mice (4–14 wk old), the ventral and dorsal halves of ears were 
split. To separate the epidermis and dermis, both halves were placed dermal 
side down on PBS 0.2% trypsin (Invitrogen) for 25 min at 37°C. In some 
experiment, PBS 0.5 M ammonium thiocyanate (Sigma-Aldrich) was used to 
separate the epidermis and dermis with a 40-min incubation at 37°C.
The epidermal sheets were fixed with PBS 3% paraformaldehyde, washed, 
and permeabilized in PBS 0.5% Triton X-100 (Sigma-Aldrich) for 15 min. 
Sheets were blocked by normal goat IgG (Invitrogen) in PBS 0.5% Triton 
X-100 (staining buffer) for 30 min before overnight labeling with rat anti–
mouse Ki67 (clone TEC-3; Dako), CD45 (clone 30-F11; BD), langerin (clone 
929F3.01; Dendritics), I-A/I-E (clone 2G9; BD), or rat anti–hamster CD11c 
(clone HL3; BD) antibodies. Samples were washed and incubated with Cy3-
conjugated goat anti–rat or Cy3-conjugated goat anti–hamster antibodies 
(Jackson ImmunoResearch Laboratories, Inc.). To avoid antibody cross-
reactions, sheets were blocked with staining buffer supplemented with normal 
rat IgG (Invitrogen) and further labeled with either rabbit anti-eGFP (Invitro-
gen) or rabbit antilangerin (clone M-200; Santa Cruz Biotechnology, Inc.). 
Samples were washed and labeled with Alexa Fluor 488–conjugated goat 
anti–rabbit (Invitrogen). Sheets were mounted in mounting medium (Vector 
Laboratories) complemented with DAPI (diluted 1:1,000; Invitrogen) for 
nuclei staining.
Figure 7. Comparison of the classical model of myeloid cell homeostasis and LC homeostasis. (A) Classical model for cell proliferation and dif-
ferentiation. Precursors are located in a niche (e.g., the bone marrow), self-renew, and give rise to proliferating committed progenitors and precursors. 
Precursors with a limited differentiation potential migrate to the peripheral tissue and complete their differentiation. During the life of the animal, when 
differentiated cells die, new precursors will migrate from the bone marrow to replace them. (B) LC precursors are recruited into the epidermis as a single 
wave before birth and differentiate in situ, and then proliferate to form a network. No further input from the progenitors is needed. During life, differen-
tiated cells can enter the cell cycle when required.
JEM VOL. 206, December 21, 2009 
Article
3099
three-dimensional reconstructed Z-stacks of epidermal langerin-GFP+ cells 
(green) expressing the proliferation nuclear factor Ki67 (red) in the epider-
mis of a mouse at day 4 after birth (Video 1) and 8-wk-old mice (Videos 
2, 3, and 4). Video 5 shows three-dimensional reconstructed Z-stacks of 
human epidermal langerin+ cells (green) expressing the proliferation nuclear 
factor Ki67 (red) in the epidermis of a healthy human donor. Nuclei are 
labeled in blue. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091586/DC1.
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